title: Myopathy after switching from brand to generic atorvastatin.
authors: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
authors: Omodele
authors: O
authors: Awoniyi
authors: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
authors: Aidar R
authors: AR
authors: Gosmanov
mesh_terms: D000368:Aged; D000069059:Atorvastatin; D001774:Blood Chemical Analysis; D016568:Drugs, Generic / Q000009:adverse effects*; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced*; D019338:Polypharmacy; D011758:Pyrroles / Q000009:adverse effects*
chemical_list: D016568:Drugs, Generic; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin